Igene Biotechnology, Inc.
IGNE · OTC
12/31/2009 | 12/31/2008 | 12/31/2007 | 12/31/2006 | |
|---|---|---|---|---|
| Market Cap | $15,378 | $1,122 | $1,426 | $3,252 |
| - Cash | $1,295 | $1,488 | $1,026 | $22 |
| + Debt | $6,796 | $5,354 | $19,330 | $16,017 |
| Enterprise Value | $20,879 | $4,988 | $19,730 | $19,247 |
| Revenue | $3,958 | $7,644 | $2,287 | $0 |
| % Growth | -48.2% | 234.3% | – | – |
| Gross Profit | $1,016 | $1,249 | $605 | $0 |
| % Margin | 25.7% | 16.3% | 26.5% | – |
| EBITDA | -$851 | -$2,080 | $325 | -$308 |
| % Margin | -21.5% | -27.2% | 14.2% | – |
| Net Income | -$141 | -$3,991 | -$1,899 | -$1,156 |
| % Margin | -3.6% | -52.2% | -83% | – |
| EPS Diluted | -0 | -0.021 | -0.017 | -0.011 |
| % Growth | 99.5% | -23.1% | -61.7% | – |
| Operating Cash Flow | -$97 | $706 | $1,310 | $0 |
| Capital Expenditures | -$172 | -$226 | -$275 | $0 |
| Free Cash Flow | -$269 | $479 | $1,035 | $0 |